Literature DB >> 23084855

Acellular pertussis vaccines in China.

Lichan Wang1, Dianliang Lei, Shumin Zhang.   

Abstract

In China, whole-cell pertussis (Pw) vaccines were produced in the early 1960s and acellular pertussis (Pa) vaccines were introduced in 1995. Pa vaccines have now almost completely replaced Pw vaccines in the national immunization program. To strengthen the regulation of vaccines used in China, a vaccine lot release system was established in 2001 and Pa vaccines have been included in the system since 2006. This paper mainly described the current status of production and the quality control measures in place for Pa vaccines; and analyses quality control test data accumulated between 2006 and 2010.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23084855     DOI: 10.1016/j.vaccine.2012.10.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  A freeze-stable formulation for DTwP and DTaP vaccines.

Authors:  Honggang Xue; Bangling Yang; Debra D Kristensen; Dexiang Chen
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Characterization of co-purified acellular pertussis vaccines.

Authors:  Yinghua Xu; Yajun Tan; Catpagavalli Asokanathan; Shumin Zhang; Dorothy Xing; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Seroprevalence of pertussis in China: need to improve vaccination strategies.

Authors:  Yinghua Xu; Lichan Wang; Jin Xu; Xinjian Wang; Chen Wei; Peng Luo; Xiao Ma; Qiming Hou; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

4.  Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China.

Authors:  Hanqing He; Pingping Yao; Yang Zhou; Xuan Deng; Jinren Pan
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

5.  Burden of whooping cough in China (PertussisChina): study protocol of a prospective, population-based case-control study.

Authors:  Jianxing Yu; Hanqing He; Yanyang Zhang; Yuan Gao; Chuanwei Chen; Juan Xu; Li Xu; Xiaoxiao Zhang; Qianqian Zhou; Yao Zhu; Xuewen Tang; Yonghao Guo; Zhiping Chen; Zhujun Shao
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

Review 6.  Exposure to mercury and aluminum in early life: developmental vulnerability as a modifying factor in neurologic and immunologic effects.

Authors:  José G Dórea
Journal:  Int J Environ Res Public Health       Date:  2015-01-23       Impact factor: 3.390

7.  Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China.

Authors:  Qinghong Meng; Lijun Li; Wei Shi; Qing Wang; Mingjie Ding; Yanqin Liu; Xiang Ma; Kaihu Yao
Journal:  BMC Pediatr       Date:  2018-12-05       Impact factor: 2.125

8.  Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing.

Authors:  Qing-Hong Meng; Ying Liu; Jin-Qian Yu; Li-Jun Li; Wei Shi; Ying-Jie Shen; Li Li; Shi-Na Zhan; Fan Yang; Ya-Juan Wang; Kai-Hu Yao
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

9.  Time series analysis of temporal trends in the pertussis incidence in Mainland China from 2005 to 2016.

Authors:  Qianglin Zeng; Dandan Li; Gui Huang; Jin Xia; Xiaoming Wang; Yamei Zhang; Wanping Tang; Hui Zhou
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

10.  Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives.

Authors:  Marieke Hoonakker; Juan Arciniega; Coenraad Hendriksen
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.